irinotecan has been researched along with Optic Nerve Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, R; Bailey, S; Bowman, R; Carceller, F; Collins, R; Corley, E; D'Arco, F; Dahl, C; English, M; Green, K; Hargrave, D; Howells, L; Jorgensen, M; Kamal, A; Kilday, JJ; Lowis, S; Lumb, B; O'Hare, P; Opocher, E; Pace, E; Panagopoulou, P; Patel, P; Picton, S; Pizer, B; Shafiq, A; Slater, O; Uzunova, L; Walters, B; Wayman, H; Wilson, S | 1 |
| Bhardwaj, RD; Nakaji, P; Ponce, FA; Rosenfeld, A; Xu, DS | 1 |
2 other study(ies) available for irinotecan and Optic Nerve Glioma
| Article | Year |
|---|---|
A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes.
Topics: Bevacizumab; Child; Humans; Irinotecan; Optic Nerve Glioma; United Kingdom; Visual Acuity | 2023 |
Cerebral peduncle tumor ablated by novel 3-mm laser tip.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Camptothecin; Cerebral Peduncle; Child; Combined Modality Therapy; Dacarbazine; Glioma; Humans; Infratentorial Neoplasms; Irinotecan; Laser Therapy; Male; Neoplasms, Multiple Primary; Neurofibromatosis 1; Neuroimaging; Optic Nerve Glioma; Supratentorial Neoplasms; Temozolomide | 2015 |